[ad_1]
The institute has claimed that the Department of Drug Administration has given permission to test the G-Rapid.blot kit, a coronavirus test invented by researchers at the Center for Public Health. However, the drug administration says it does not allow any testing. Instead, the kit has been sent to two recognized organizations for verification.
On Thursday, a notice was sent to the media on behalf of the government agency to eliminate the misconception in this regard.
Director General of the Department of Drug Administration, Major General. The press release signed by Mahbubur Rahman said various media reports that the GR Covid-19 Rapid Spot Erase Immunoassay Kit invented by Messrs. Gonoshastha Pharmaceuticals Limited has been approved by the Department of Drug Administration for testing . Which is not correct. In fact, the kit performance test has been passed by CR0-3: ICDDRB and CR0-10: BSMMU approved by the Drug Administration in accordance with all rules and regulations at the request of Public Health Pharmaceuticals Limited.
The notification also said that the next necessary action will be taken based on the results obtained at the end of these performance tests.
Earlier this afternoon, the founder and administrator of the Public Health Center. Jafrullah Chowdhury said: ‘We have been allowed to test the kit. The Department of Drug Administration has said that the test should be done at Bangabandhu Sheikh Mujib Medical University (BSMMU) or at ICDDR, B.
Meanwhile, the Department of Drug Administration has written a letter to the BSMMU Vice Chancellor, said the founder of the public health center.
[ad_2]
